Urology · Milwaukee, WI
NPI
1447695317
Since 2013
Specialty
Urology
Code 208800000X
Group practices
4
Medicare group memberships
Hospitals
1
Hospital affiliations
9200 W Wisconsin Ave
Milwaukee, WI, 53226
Phone (414) 805-0805
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
2,420 services
Medicare patients, 2024
192
Average age 75
Drug cost, 2024
$101K
893 prescriptions
Company payments, 2025
$1,070
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Graham L Machen was code J9030 (bcg live intravesical instillation, 1 mg), 1,400 times for 16 patients. In total Graham L Machen billed 2,420 services in 55 codes, and Medicare paid $40K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 1,400 | 16 | $2.19 | $3,072 |
| 99214 Office E&M - Established | Office | 94 | 72 | $82.18 | $7,725 |
| 81003 Clinical Chemistry | Office | 83 | 65 | $2.17 | $180 |
| 81001 Clinical Chemistry | Office | 72 | 54 | $3.11 | $224 |
| 51702 Other Organ Systems | Office | 35 | 20 | $39.15 | $1,370 |
| 99213 Office E&M - Established | Office | 32 | 30 | $60.82 | $1,946 |
| 99204 Office E&M - New | Office | 30 | 30 | $92.82 | $2,785 |
| 51720 Chemotherapy Administration | Office | 28 | 16 | $62.25 | $1,743 |
| 51705 Other Organ Systems | Office | 18 | 11 | $63.68 | $1,146 |
| 51798 Ultrasound - Nonspecific | Office | 15 | 14 | $8.12 | $122 |
By year: 2022 $3,361 for 88 services; 2023 $37K for 2,490 services; 2024 $40K for 2,420 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 83 | 65 | $2.17 | $180 |
| 81001 Clinical Chemistry | 72 | 54 | $3.11 | $224 |
Medicare prescription drug claims, 2024
In 2024, the drug Graham L Machen prescribed most often to Medicare patients was Tamsulosin Hcl, with 207 prescriptions and refills. In total Graham L Machen wrote 893 Medicare prescriptions that cost $101K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 207 | 490 | 74 | $2,264 |
| Myrbetriq Mirabegron | 71 | 92 | 24 | $40K |
| Finasteride Generic | 69 | 190 | 29 | $843 |
| Celecoxib Generic | 67 | 67 | 47 | $689 |
| Oxycodone Hcl Generic | 52 | 52 | 48 | $171 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 51 | 51 | 43 | $239 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 40 | 57 | 18 | $1,836 |
| Meloxicam Generic | 36 | 36 | 20 | $54.1 |
| Testosterone Cypionate Generic | 31 | 58 | 20 | $1,560 |
| Testosterone Generic | 29 | 38 | Under 11 | $3,247 |
| Jatenzo Testosterone Undecanoate | 23 | 39 | Under 11 | $33K |
| Anastrozole Generic | 21 | 37 | Under 11 | $270 |
| Levofloxacin Generic | 19 | 19 | 16 | $2,558 |
| Cephalexin Generic | 17 | 24 | 11 | $447 |
| Tramadol Hcl Generic | 17 | 17 | 17 | $33.25 |
Brand drugs: 128 claims; generic drugs: 765 claims; opioid claims: 74.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Graham L Machen $1,070 ($1,070 in general payments such as food, travel and fees) from 18 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $174.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 9 | $174 |
| Coloplast Corp | 5 | $169 |
| Novartis Pharmaceuticals Corporation NVS | 5 | $130 |
| Boston Scientific Corporation BSX | 2 | $119 |
| Merck Sharp & Dohme LLC MRK | 4 | $102 |
| Abbvie Inc. ABBV | 4 | $72.68 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $51.19 |
| Verity Pharmaceuticals Inc. | 2 | $37.59 |
| Janssen Biotech, Inc. JNJ | 2 | $34.56 |
| Astellas Pharma US Inc 4503.T | 1 | $29.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.